New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
source: pixabay.com

New Treatment Approved in Canada for Gastrointestinal Stromal Tumor

According to a story from Biotech 365, the biopharmaceutical company Deciphera Pharmaceuticals has recently announced that the company's drug ripretinib (marketed as QINLOCK™) has been approved by Health Canada. The…

Continue Reading New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
A New Phase 2 Trial Begins for Experimental Nonalcoholic Steatohepatitis Treatment
source: pixabay.com

A New Phase 2 Trial Begins for Experimental Nonalcoholic Steatohepatitis Treatment

According to a story from globenewswire.com, the biotechnology company CytoDyn Inc. has recently announced the initiation of a phase 2 clinical trial. This clinical trial will be testing the company's…

Continue Reading A New Phase 2 Trial Begins for Experimental Nonalcoholic Steatohepatitis Treatment
The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
source: pixabay.com

The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has just approved a treatment for rare adult-onset Still's disease for the first time ever. The…

Continue Reading The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy
source: pixabay.com

New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy

According to a story from BioPharma Dive, the drug company Sarepta Therapeutics is pushing forward with its plans to develop a gene therapy for limb-girdle muscular dystrophy (LGMD). The company…

Continue Reading New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy
June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Scleroderma Awareness Month: Spreading Rare Disease Awareness

According to a story from Scleroderma News, June is recognized as Scleroderma Awareness Month. While physical distancing as a result of the ongoing coronavirus/COVID-19 pandemic may keep some folks at…

Continue Reading June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
Portuguese Authorities Approve Treatment for HATTR Amyloidosis Polyneuropathy
source: pixabay.com

Portuguese Authorities Approve Treatment for HATTR Amyloidosis Polyneuropathy

According to a story from PR Newswire, Akcea Therapeutics, Inc. recently announced that the Portuguese Medicine Regulatory Authority (INFARMED) has announced its approval of reimbursement for inotersen (marketed as TEGSEDI®)…

Continue Reading Portuguese Authorities Approve Treatment for HATTR Amyloidosis Polyneuropathy
Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals has recently announced that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to its…

Continue Reading Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
NORD Announces Eleven New Grants for Rare Disease Research
source: pixabay.com

NORD Announces Eleven New Grants for Rare Disease Research

According to a story from PR Newswire, the National Organization for Rare Disorders (NORD) has recently awarded a total of eleven new grant awards that will help fund essential research…

Continue Reading NORD Announces Eleven New Grants for Rare Disease Research